ExodusPoint Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

ExodusPoint Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,066	Closed	-$170K	–	2570
2020 Q3	$170K	Sell	18,066 -118,252	-87%	-$1.12M	﹤0.01%	1516
2020 Q2	$1.04M	Buy	+136,318	New	+$1.04M	0.03%	720
2019 Q4	–	Sell	-18,786	Closed	-$217K	–	2039
2019 Q3	$217K	Buy	18,786 +6,567	+54%	+$69.1K	0.01%	1083
2019 Q2	$122K	Buy	+12,219	New	+$132K	﹤0.01%	1005

ExodusPoint Capital Management's AMAG Position: Q4 2020 in Review

ExodusPoint Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 18,066 shares — an estimated $170K sold.

ExodusPoint Capital Management first reported a position in AMAG in Q2 2019 and held it in 4 quarters. The position peaked at $1.04M in Q2 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

ExodusPoint Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
ExodusPoint Capital Management sold 18,066 AMAG Pharmaceuticals shares in Q4 2020, an estimated $170K.
ExodusPoint Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2019 and held it in 4 quarters.
ExodusPoint Capital Management's AMAG Pharmaceuticals position peaked at $1.04M in Q2 2020.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.